MiMedx Group, Inc. Shares Sold by Richmond Brothers Inc. - MarketBeat
| MDXG Stock | USD 9.20 0.02 0.22% |
Roughly 53% of MiMedx's investor base is interested to short. The analysis of the overall investor sentiment regarding MiMedx Group suggests that many traders are impartial. The current market sentiment, together with MiMedx's historical and current headlines, can help investors time the market. In addition, many technical investors use MiMedx Group stock news signals to limit their universe of possible portfolio assets.
MiMedx |
MiMedx Group, Inc. Shares Sold by Richmond Brothers Inc. MarketBeat
Read at news.google.com
 |
MiMedx Fundamental Analysis
We analyze MiMedx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MiMedx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MiMedx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
MiMedx is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
MiMedx Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
Peers
MiMedx Related Equities
| PTGX | Protagonist Therapeutics | 11.55 | ||||
| GPCR | Structure Therapeutics | 11.00 | ||||
| CVKD | Cadrenal Therapeutics, | 7.00 | ||||
| HOWL | Werewolf Therapeutics | 6.74 | ||||
| CCCC | C4 Therapeutics | 5.99 | ||||
| MLYS | Mineralys Therapeutics, | 5.22 | ||||
| INZY | Inozyme Pharma | 4.46 | ||||
| NVCT | Nuvectis Pharma | 4.08 | ||||
| KROS | Keros Therapeutics | 3.86 | ||||
| ERAS | Erasca | 3.85 | ||||
| SNDX | Syndax Pharmaceuticals | 3.14 | ||||
| DAWN | Day One | 2.85 | ||||
| CGEM | Cullinan Oncology | 2.62 | ||||
| GLUE | Monte Rosa | 1.68 | ||||
| ZNTL | Zentalis Pharmaceuticals | 1.57 | ||||
| STOK | Stoke Therapeutics | 1.42 | ||||
| DSGN | Design Therapeutics | 0.90 | ||||
| EWTX | Edgewise Therapeutics | 0.69 | ||||
| IKNA | Ikena Oncology | 1.16 | ||||
| IPSC | Century Therapeutics | 2.42 | ||||
| CNTA | Centessa Pharmaceuticals | 6.32 |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |